This book provides a complete approach to the economics of financing medicines and policy implications for the efficiency and equity of health systems. In all health systems with majority public financing, pharmaceutical reimbursement is one of the key factors in policies of change and transformation of health services in order to face the future with guarantees of financial sustainability.
The initial chapters seek to answer questions about the efficiency with which the public sector intervenes in the pharmaceutical industry: Is the present system of drug patents efficient and fair? What would be the best way to control drug prices? Is it possible to encourage competition in this market for the patient's benefit? The remainder of the book provides evidence on the impact of instruments and policies aimed at rationalising and controlling pharmaceutical expenditure: What can we expect from the application of reference pricing systems? When, how and where should the user be made to share the cost of medicines? What economic and non-economic incentives should be applied to drug prescription?
Jaume Puig-Junoy has performed an invaluable task in creating a cohesive, and analytically rigorous book of specially commissioned chapters on this pertinent topic.
The Public Financing of Pharmaceuticals will appeal to academics and researchers involved in public finance, health policy, health economics, industrial organisation and the pharmaceutical markets in Europe and in the US, where there is increasing public interest in drug coverage. The book is also intended for a wide variety of professionals in the health industries and policymakers.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Edited by Jaume Puig-Junoy, Research Centre for Economics and Health (CRES), Department of Economics and Business, Pompeu Fabra University, Spain
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
EUR 14,91 für den Versand von Vereinigtes Königreich nach USA
Versandziele, Kosten & DauerEUR 34,56 für den Versand von Vereinigtes Königreich nach USA
Versandziele, Kosten & DauerAnbieter: Anybook.com, Lincoln, Vereinigtes Königreich
Zustand: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. Clean from markings. With owner's name inside cover. In good all round condition. Dust jacket in good condition. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,600grams, ISBN:9781845420888. Bestandsnummer des Verkäufers 9849528
Anzahl: 1 verfügbar
Anbieter: killarneybooks, Inagh, CLARE, Irland
Hardcover. Zustand: Fine. Zustand des Schutzumschlags: Near Fine. Hardcover, xiii + 255pp, index, NOT ex-library. Weight: 0.57kg / 1.24lb. A fine copy with clean and bright interior, firm binding, unmarked text; free of stamps and inscriptions. Dust jacket shows gentle creasing along the edges. --- This book provides a complete approach to the economics of financing medicines and policy implications for the efficiency and equity of health systems. In all health systems with majority public financing, pharmaceutical reimbursement is one of the key factors in policies of change and transformation of health services in order to face the future with guarantees of financial sustainability. The initial chapters seek to answer questions about the efficiency with which the public sector intervenes in the pharmaceutical industry: Is the present system of drug patents efficient and fair? What would be the best way to control drug prices? Is it possible to encourage competition in this market for the patient's benefit? The remainder of the book provides evidence on the impact of instruments and policies aimed at rationalising and controlling pharmaceutical expenditure: What can we expect from the application of reference pricing systems? When, how and where should the user be made to share the cost of medicines? What economic and non-economic incentives should be applied to drug prescription? -- Contents: 1. Introduction: Public Pharmaceutical Expenditure / Jaume Puig-Junoy; -- Part I -- 2. Incentives for Innovation in the Pharmaceutical Market / P. Ibern Regàs; 3. Price Regulation Systems in the Pharmaceutical Market / Jaume Puig-Junoy; 4. Regulation and Competition in Pharmaceutical Markets / Joan Ramon Borrell Arqué; 5. Mechanisms to Encourage Price Competition in the Pharmaceutical Market and their Effects on Efficiency and Welfare / J. Rovira Forns; -- Part II -- 6. Reference Pricing as a Pharmaceutical Reimbursement Mechanism / Guillem López Casasnovas; 7. Insurance in Public Financing of Pharmaceuticals / Beatriz González López-Valcárcel; 8. Economic Evaluation and Pharmaceutical Policy / José Luis Pinto Prades; 9. Prescriber Incentives / L. Cabiedes and V. Ortún; -- Part III -- 10. Economic Considerations Regarding Pharmaceutical Expenditure in Spain and its Financing / Guillem López Casasnovas; 11. Review of Economic Studies of the Pharmaceutical Industry Published Over the Last 20 Years by Spanish Economists / F. Lobo; Appendix: List of Economic Studies of the Pharmaceutical Industry and Pharmaceuticals Published Over the Last 20 Years by Spanish Economists; Index. Bestandsnummer des Verkäufers 002793
Anzahl: 1 verfügbar
Anbieter: medimops, Berlin, Deutschland
Zustand: very good. Gut/Very good: Buch bzw. Schutzumschlag mit wenigen Gebrauchsspuren an Einband, Schutzumschlag oder Seiten. / Describes a book or dust jacket that does show some signs of wear on either the binding, dust jacket or pages. Bestandsnummer des Verkäufers M01845420888-V
Anzahl: 1 verfügbar
Anbieter: Cotswold Internet Books, Cheltenham, Vereinigtes Königreich
1st edition. A tidy copy in tight binding. Used - Very Good. VG hardback in VG dustjacket. Bestandsnummer des Verkäufers BOOKS105244I
Anzahl: 1 verfügbar
Anbieter: StainesBook, Weybridge, SURRE, Vereinigtes Königreich
Bestandsnummer des Verkäufers SpeedList-1929
Anzahl: 5 verfügbar
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Bestandsnummer des Verkäufers ABNR-193744
Anzahl: 1 verfügbar
Anbieter: Basi6 International, Irving, TX, USA
Zustand: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Bestandsnummer des Verkäufers ABEJUNE24-240859
Anzahl: 1 verfügbar
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. Bestandsnummer des Verkäufers 26134134573
Anzahl: 1 verfügbar
Anbieter: ALLBOOKS1, Direk, SA, Australien
Bestandsnummer des Verkäufers SHUB240859
Anzahl: 1 verfügbar
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Zustand: New. Bestandsnummer des Verkäufers 126420210
Anzahl: 1 verfügbar